| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Neoplasms | 28 | 2024 | 1502 | 3.900 |
Why?
|
| Genetic Predisposition to Disease | 17 | 2024 | 628 | 2.170 |
Why?
|
| Prostatic Neoplasms | 19 | 2023 | 935 | 1.760 |
Why?
|
| Mammography | 6 | 2019 | 188 | 1.730 |
Why?
|
| Papillomavirus Infections | 6 | 2017 | 336 | 1.500 |
Why?
|
| Diabetes Mellitus | 5 | 2019 | 485 | 1.470 |
Why?
|
| Papillomavirus Vaccines | 4 | 2017 | 151 | 1.300 |
Why?
|
| Genome-Wide Association Study | 13 | 2024 | 333 | 1.260 |
Why?
|
| Patient Education as Topic | 5 | 2019 | 215 | 1.250 |
Why?
|
| Female | 81 | 2024 | 20969 | 1.250 |
Why?
|
| Health Knowledge, Attitudes, Practice | 7 | 2021 | 864 | 1.240 |
Why?
|
| Aged | 38 | 2024 | 6741 | 1.200 |
Why?
|
| Adult | 56 | 2024 | 11712 | 1.170 |
Why?
|
| Humans | 109 | 2024 | 37093 | 1.170 |
Why?
|
| Middle Aged | 46 | 2024 | 10129 | 1.160 |
Why?
|
| Case-Control Studies | 24 | 2024 | 1130 | 1.010 |
Why?
|
| Attitude to Health | 3 | 2019 | 325 | 0.960 |
Why?
|
| Arm | 1 | 2024 | 28 | 0.960 |
Why?
|
| Risk Factors | 26 | 2024 | 3562 | 0.870 |
Why?
|
| Polymorphism, Single Nucleotide | 13 | 2024 | 767 | 0.850 |
Why?
|
| Breast | 2 | 2021 | 135 | 0.820 |
Why?
|
| Reproductive History | 1 | 2021 | 19 | 0.780 |
Why?
|
| Obesity | 7 | 2022 | 1067 | 0.740 |
Why?
|
| Postmenopause | 3 | 2019 | 128 | 0.730 |
Why?
|
| Exercise | 3 | 2024 | 613 | 0.730 |
Why?
|
| Male | 53 | 2024 | 20025 | 0.700 |
Why?
|
| Child Abuse | 1 | 2021 | 79 | 0.690 |
Why?
|
| Texas | 12 | 2015 | 324 | 0.680 |
Why?
|
| Cross-Sectional Studies | 19 | 2023 | 2721 | 0.680 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2017 | 643 | 0.680 |
Why?
|
| Poverty Areas | 1 | 2018 | 41 | 0.640 |
Why?
|
| Genetic Testing | 1 | 2019 | 75 | 0.640 |
Why?
|
| Cohort Studies | 14 | 2024 | 1492 | 0.640 |
Why?
|
| Multifactorial Inheritance | 4 | 2024 | 19 | 0.640 |
Why?
|
| Mammary Glands, Human | 2 | 2015 | 39 | 0.610 |
Why?
|
| Health Services Accessibility | 4 | 2019 | 560 | 0.580 |
Why?
|
| Early Detection of Cancer | 7 | 2022 | 336 | 0.560 |
Why?
|
| Genetic Loci | 5 | 2024 | 90 | 0.550 |
Why?
|
| Pregnancy, Unplanned | 2 | 2007 | 29 | 0.550 |
Why?
|
| Aftercare | 1 | 2015 | 19 | 0.540 |
Why?
|
| Uterine Cervical Neoplasms | 4 | 2017 | 277 | 0.520 |
Why?
|
| Odds Ratio | 9 | 2021 | 534 | 0.520 |
Why?
|
| Southeastern United States | 5 | 2022 | 49 | 0.510 |
Why?
|
| Lung Neoplasms | 2 | 2019 | 358 | 0.510 |
Why?
|
| Healthcare Disparities | 2 | 2017 | 494 | 0.500 |
Why?
|
| Tennessee | 6 | 2020 | 70 | 0.500 |
Why?
|
| Adolescent | 20 | 2017 | 5363 | 0.500 |
Why?
|
| Social Marketing | 1 | 2014 | 25 | 0.470 |
Why?
|
| Energy Metabolism | 1 | 2015 | 168 | 0.470 |
Why?
|
| Culture | 2 | 2018 | 173 | 0.460 |
Why?
|
| Socioeconomic Factors | 10 | 2019 | 1067 | 0.430 |
Why?
|
| Child | 8 | 2023 | 3131 | 0.410 |
Why?
|
| Health Status Indicators | 3 | 2010 | 75 | 0.400 |
Why?
|
| Registries | 5 | 2015 | 335 | 0.400 |
Why?
|
| Dementia | 2 | 2003 | 131 | 0.400 |
Why?
|
| Prospective Studies | 5 | 2021 | 1378 | 0.400 |
Why?
|
| Mexico | 6 | 2015 | 240 | 0.390 |
Why?
|
| Risk | 5 | 2019 | 267 | 0.370 |
Why?
|
| Intention | 2 | 2017 | 94 | 0.370 |
Why?
|
| Domestic Violence | 3 | 2008 | 30 | 0.370 |
Why?
|
| Logistic Models | 8 | 2024 | 923 | 0.370 |
Why?
|
| Body Mass Index | 8 | 2022 | 854 | 0.360 |
Why?
|
| Breast Feeding | 2 | 2010 | 113 | 0.360 |
Why?
|
| Receptors, Progesterone | 3 | 2022 | 81 | 0.350 |
Why?
|
| Premenopause | 4 | 2022 | 104 | 0.350 |
Why?
|
| Risk Assessment | 8 | 2023 | 753 | 0.350 |
Why?
|
| United States | 13 | 2024 | 4223 | 0.350 |
Why?
|
| Receptors, Estrogen | 3 | 2024 | 156 | 0.350 |
Why?
|
| Aged, 80 and over | 7 | 2021 | 2379 | 0.350 |
Why?
|
| Fathers | 2 | 2010 | 33 | 0.340 |
Why?
|
| Pregnancy | 16 | 2013 | 1549 | 0.340 |
Why?
|
| Receptor, erbB-2 | 3 | 2022 | 133 | 0.330 |
Why?
|
| Papillomaviridae | 1 | 2009 | 127 | 0.330 |
Why?
|
| Health Promotion | 2 | 2014 | 653 | 0.310 |
Why?
|
| Proportional Hazards Models | 5 | 2020 | 441 | 0.310 |
Why?
|
| Follow-Up Studies | 4 | 2017 | 974 | 0.310 |
Why?
|
| Patient Acceptance of Health Care | 3 | 2017 | 404 | 0.310 |
Why?
|
| South Carolina | 7 | 2006 | 25 | 0.290 |
Why?
|
| Qualitative Research | 6 | 2023 | 446 | 0.290 |
Why?
|
| Adiposity | 3 | 2017 | 154 | 0.280 |
Why?
|
| Young Adult | 7 | 2021 | 4268 | 0.280 |
Why?
|
| Incidence | 4 | 2018 | 922 | 0.270 |
Why?
|
| Pregnancy, Unwanted | 2 | 2005 | 10 | 0.270 |
Why?
|
| Risk-Taking | 2 | 2006 | 451 | 0.260 |
Why?
|
| Health Education | 2 | 2020 | 338 | 0.260 |
Why?
|
| Focus Groups | 4 | 2020 | 348 | 0.250 |
Why?
|
| Life Style | 3 | 2011 | 308 | 0.250 |
Why?
|
| Cardiovascular Diseases | 2 | 2021 | 664 | 0.250 |
Why?
|
| Smoking | 4 | 2024 | 940 | 0.250 |
Why?
|
| Growth Disorders | 1 | 2004 | 22 | 0.250 |
Why?
|
| Lymphedema | 1 | 2024 | 8 | 0.250 |
Why?
|
| Age Factors | 6 | 2021 | 1033 | 0.240 |
Why?
|
| Health Status | 2 | 2009 | 380 | 0.240 |
Why?
|
| Gestational Age | 7 | 2011 | 190 | 0.230 |
Why?
|
| Social Identification | 1 | 2004 | 58 | 0.230 |
Why?
|
| Soybean Proteins | 1 | 2004 | 38 | 0.230 |
Why?
|
| Students | 3 | 2008 | 519 | 0.230 |
Why?
|
| Fetal Growth Retardation | 4 | 2010 | 50 | 0.230 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2004 | 70 | 0.230 |
Why?
|
| Germ Cells | 2 | 2022 | 73 | 0.220 |
Why?
|
| Obstetrics | 3 | 2008 | 37 | 0.220 |
Why?
|
| Fetal Weight | 3 | 2010 | 9 | 0.220 |
Why?
|
| Retrospective Studies | 10 | 2021 | 2026 | 0.220 |
Why?
|
| Vaccination | 3 | 2023 | 288 | 0.220 |
Why?
|
| Sexual Harassment | 1 | 2002 | 5 | 0.220 |
Why?
|
| Ultrasonography, Prenatal | 3 | 2010 | 33 | 0.210 |
Why?
|
| Arthritis | 1 | 2022 | 15 | 0.210 |
Why?
|
| Chronic Disease | 3 | 2021 | 484 | 0.210 |
Why?
|
| Acculturation | 1 | 2004 | 188 | 0.210 |
Why?
|
| Dementia, Multi-Infarct | 1 | 2002 | 1 | 0.210 |
Why?
|
| Mexican Americans | 4 | 2010 | 189 | 0.210 |
Why?
|
| Clinical Trials as Topic | 2 | 2021 | 204 | 0.210 |
Why?
|
| Anemia | 1 | 2002 | 45 | 0.200 |
Why?
|
| Crime Victims | 1 | 2002 | 77 | 0.200 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2021 | 27 | 0.200 |
Why?
|
| Social Class | 3 | 2017 | 247 | 0.200 |
Why?
|
| Poverty | 2 | 2014 | 348 | 0.190 |
Why?
|
| Gene Deletion | 1 | 2021 | 166 | 0.190 |
Why?
|
| Population Surveillance | 4 | 2015 | 238 | 0.190 |
Why?
|
| Body Height | 1 | 2021 | 53 | 0.190 |
Why?
|
| Motivation | 3 | 2023 | 436 | 0.190 |
Why?
|
| Sex Factors | 3 | 2018 | 898 | 0.180 |
Why?
|
| Social Support | 3 | 2010 | 394 | 0.180 |
Why?
|
| Models, Genetic | 1 | 2020 | 172 | 0.180 |
Why?
|
| Research Subjects | 1 | 2020 | 32 | 0.180 |
Why?
|
| Family Characteristics | 1 | 2021 | 108 | 0.180 |
Why?
|
| Women's Health | 2 | 2011 | 145 | 0.180 |
Why?
|
| Time Factors | 4 | 2018 | 1742 | 0.170 |
Why?
|
| Motor Activity | 2 | 2014 | 418 | 0.170 |
Why?
|
| Health Personnel | 2 | 2023 | 228 | 0.170 |
Why?
|
| Dystocia | 3 | 2008 | 5 | 0.170 |
Why?
|
| Mental Health | 1 | 2002 | 303 | 0.160 |
Why?
|
| Patient Satisfaction | 1 | 2019 | 145 | 0.160 |
Why?
|
| Community-Institutional Relations | 1 | 2020 | 187 | 0.160 |
Why?
|
| Schools, Medical | 1 | 2020 | 198 | 0.160 |
Why?
|
| Alzheimer Disease | 2 | 2003 | 905 | 0.160 |
Why?
|
| Prevalence | 4 | 2014 | 1455 | 0.160 |
Why?
|
| Depression | 2 | 2022 | 712 | 0.150 |
Why?
|
| Cesarean Section | 2 | 2008 | 55 | 0.150 |
Why?
|
| Pregnancy Outcome | 3 | 2008 | 87 | 0.150 |
Why?
|
| Prostate-Specific Antigen | 3 | 2022 | 118 | 0.150 |
Why?
|
| Menopause | 2 | 2014 | 56 | 0.150 |
Why?
|
| Body Weight | 2 | 2018 | 434 | 0.150 |
Why?
|
| Fetal Macrosomia | 3 | 2007 | 12 | 0.150 |
Why?
|
| Maternal Age | 2 | 2007 | 26 | 0.150 |
Why?
|
| Community-Based Participatory Research | 2 | 2020 | 317 | 0.150 |
Why?
|
| Serine Endopeptidases | 1 | 2017 | 38 | 0.150 |
Why?
|
| Biological Specimen Banks | 1 | 2017 | 25 | 0.140 |
Why?
|
| Quality Indicators, Health Care | 1 | 2017 | 40 | 0.140 |
Why?
|
| Bolivia | 2 | 2007 | 9 | 0.140 |
Why?
|
| Anthropometry | 4 | 2017 | 97 | 0.140 |
Why?
|
| Practice Guidelines as Topic | 2 | 2008 | 191 | 0.140 |
Why?
|
| Parenting | 1 | 2018 | 127 | 0.140 |
Why?
|
| Cluster Analysis | 1 | 2017 | 195 | 0.140 |
Why?
|
| Birth Weight | 2 | 2006 | 90 | 0.130 |
Why?
|
| Calcium, Dietary | 2 | 2015 | 85 | 0.130 |
Why?
|
| Tobacco Use Disorder | 1 | 2019 | 237 | 0.130 |
Why?
|
| Twins | 2 | 2006 | 17 | 0.130 |
Why?
|
| Biomedical Research | 1 | 2020 | 400 | 0.130 |
Why?
|
| Medicare | 1 | 2016 | 195 | 0.130 |
Why?
|
| Epidemiology | 1 | 2014 | 6 | 0.130 |
Why?
|
| Pilot Projects | 4 | 2024 | 661 | 0.130 |
Why?
|
| Disease | 1 | 2014 | 18 | 0.120 |
Why?
|
| Neoplasms | 2 | 2021 | 1103 | 0.120 |
Why?
|
| Medically Underserved Area | 1 | 2014 | 104 | 0.120 |
Why?
|
| Smoking Cessation | 2 | 2019 | 517 | 0.120 |
Why?
|
| Demography | 2 | 2006 | 175 | 0.120 |
Why?
|
| Diet | 2 | 2021 | 801 | 0.110 |
Why?
|
| Leukemia | 2 | 2004 | 56 | 0.110 |
Why?
|
| Multivariate Analysis | 3 | 2021 | 583 | 0.110 |
Why?
|
| Occupational Exposure | 2 | 2004 | 79 | 0.110 |
Why?
|
| Vitamin D | 1 | 2015 | 196 | 0.110 |
Why?
|
| Adolescent Behavior | 2 | 2006 | 253 | 0.110 |
Why?
|
| Ovarian Neoplasms | 1 | 2016 | 312 | 0.110 |
Why?
|
| Insulin | 1 | 2014 | 236 | 0.110 |
Why?
|
| Amniotic Fluid | 1 | 2011 | 15 | 0.100 |
Why?
|
| Epidemiologic Methods | 3 | 2014 | 49 | 0.100 |
Why?
|
| Intensive Care Units, Neonatal | 2 | 2008 | 42 | 0.100 |
Why?
|
| Patient Preference | 1 | 2012 | 44 | 0.100 |
Why?
|
| Germ-Line Mutation | 2 | 2022 | 57 | 0.100 |
Why?
|
| Algorithms | 1 | 2014 | 465 | 0.100 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2013 | 162 | 0.100 |
Why?
|
| Stress, Psychological | 2 | 2008 | 583 | 0.100 |
Why?
|
| Universities | 2 | 2020 | 442 | 0.100 |
Why?
|
| Obstetric Labor, Premature | 1 | 2010 | 13 | 0.090 |
Why?
|
| Parity | 2 | 2008 | 46 | 0.090 |
Why?
|
| Parents | 1 | 2014 | 329 | 0.090 |
Why?
|
| Income | 2 | 2021 | 140 | 0.090 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2010 | 62 | 0.090 |
Why?
|
| Infant | 3 | 2014 | 1046 | 0.090 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2010 | 18 | 0.090 |
Why?
|
| Mass Screening | 1 | 2014 | 462 | 0.090 |
Why?
|
| Neoplasm Invasiveness | 2 | 2021 | 251 | 0.090 |
Why?
|
| Masculinity | 1 | 2009 | 17 | 0.090 |
Why?
|
| Infant, Newborn | 6 | 2010 | 894 | 0.090 |
Why?
|
| Fetus | 1 | 2010 | 105 | 0.090 |
Why?
|
| Vaginal Smears | 1 | 2009 | 57 | 0.090 |
Why?
|
| Body Composition | 1 | 2010 | 162 | 0.090 |
Why?
|
| Child Welfare | 1 | 2009 | 42 | 0.090 |
Why?
|
| Mother-Child Relations | 1 | 2009 | 59 | 0.090 |
Why?
|
| Health Facility Environment | 1 | 2008 | 4 | 0.080 |
Why?
|
| Noise | 1 | 2008 | 9 | 0.080 |
Why?
|
| China | 3 | 2004 | 196 | 0.080 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2008 | 44 | 0.080 |
Why?
|
| Bibliometrics | 1 | 2008 | 17 | 0.080 |
Why?
|
| Fetal Distress | 1 | 2008 | 4 | 0.080 |
Why?
|
| Fetal Monitoring | 1 | 2008 | 5 | 0.080 |
Why?
|
| Heart Rate, Fetal | 1 | 2008 | 12 | 0.080 |
Why?
|
| Publishing | 1 | 2008 | 24 | 0.080 |
Why?
|
| Monocytes | 1 | 2010 | 257 | 0.080 |
Why?
|
| Group Practice | 1 | 2008 | 8 | 0.080 |
Why?
|
| Guideline Adherence | 1 | 2008 | 84 | 0.080 |
Why?
|
| Hospitals, Community | 1 | 2008 | 12 | 0.080 |
Why?
|
| Research Design | 2 | 2008 | 313 | 0.080 |
Why?
|
| Paraguay | 1 | 2007 | 1 | 0.080 |
Why?
|
| Brachial Plexus Neuropathies | 1 | 2007 | 1 | 0.080 |
Why?
|
| Birth Injuries | 1 | 2007 | 9 | 0.080 |
Why?
|
| Health Surveys | 2 | 2010 | 373 | 0.070 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2008 | 268 | 0.070 |
Why?
|
| Abdomen | 2 | 2006 | 12 | 0.070 |
Why?
|
| Child, Preschool | 2 | 2018 | 1418 | 0.070 |
Why?
|
| Body Fat Distribution | 1 | 2007 | 24 | 0.070 |
Why?
|
| Shoulder | 1 | 2006 | 9 | 0.070 |
Why?
|
| Birth Order | 1 | 2006 | 5 | 0.070 |
Why?
|
| Feasibility Studies | 2 | 2024 | 208 | 0.070 |
Why?
|
| Proxy | 1 | 2006 | 7 | 0.070 |
Why?
|
| Gene Frequency | 2 | 2017 | 195 | 0.070 |
Why?
|
| Washington | 1 | 2006 | 31 | 0.070 |
Why?
|
| Pregnancy, High-Risk | 1 | 2006 | 4 | 0.070 |
Why?
|
| Contraception | 1 | 2007 | 57 | 0.070 |
Why?
|
| Chromosome Mapping | 2 | 2017 | 188 | 0.070 |
Why?
|
| Confidence Intervals | 1 | 2006 | 149 | 0.070 |
Why?
|
| Decision Making | 2 | 2023 | 203 | 0.070 |
Why?
|
| Gynecology | 1 | 2006 | 31 | 0.070 |
Why?
|
| Societies, Medical | 1 | 2006 | 66 | 0.070 |
Why?
|
| Agriculture | 1 | 2006 | 56 | 0.070 |
Why?
|
| Evidence-Based Medicine | 1 | 2006 | 97 | 0.070 |
Why?
|
| RNA, Messenger | 1 | 2010 | 1207 | 0.070 |
Why?
|
| Leptin | 1 | 2007 | 118 | 0.070 |
Why?
|
| Behavioral Risk Factor Surveillance System | 1 | 2006 | 56 | 0.070 |
Why?
|
| Acid-Base Imbalance | 1 | 2005 | 3 | 0.060 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2005 | 18 | 0.060 |
Why?
|
| Brain Diseases | 1 | 2005 | 32 | 0.060 |
Why?
|
| Infant Welfare | 1 | 2004 | 7 | 0.060 |
Why?
|
| Social Values | 1 | 2005 | 30 | 0.060 |
Why?
|
| Sexual Behavior | 3 | 2005 | 609 | 0.060 |
Why?
|
| Maternal Behavior | 1 | 2004 | 22 | 0.060 |
Why?
|
| Blood Pressure | 1 | 2008 | 646 | 0.060 |
Why?
|
| Survival Rate | 2 | 2021 | 311 | 0.060 |
Why?
|
| Infant Mortality | 3 | 2014 | 55 | 0.060 |
Why?
|
| Chorion | 1 | 2004 | 8 | 0.060 |
Why?
|
| Spouse Abuse | 1 | 2004 | 43 | 0.060 |
Why?
|
| Regression Analysis | 3 | 2010 | 455 | 0.060 |
Why?
|
| Comorbidity | 2 | 2007 | 623 | 0.060 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2004 | 23 | 0.060 |
Why?
|
| Heart Diseases | 1 | 2005 | 104 | 0.060 |
Why?
|
| Public Health Informatics | 1 | 2003 | 8 | 0.060 |
Why?
|
| Occupations | 1 | 2003 | 23 | 0.060 |
Why?
|
| Hazardous Substances | 1 | 2003 | 18 | 0.060 |
Why?
|
| Placenta | 1 | 2004 | 97 | 0.060 |
Why?
|
| Ultrasonography | 3 | 2011 | 112 | 0.060 |
Why?
|
| Sensitivity and Specificity | 4 | 2008 | 562 | 0.060 |
Why?
|
| Meta-Analysis as Topic | 2 | 2016 | 30 | 0.060 |
Why?
|
| Data Collection | 1 | 2004 | 194 | 0.060 |
Why?
|
| Waist-Hip Ratio | 2 | 2017 | 34 | 0.060 |
Why?
|
| Alleles | 1 | 2024 | 321 | 0.060 |
Why?
|
| Kidney Diseases | 1 | 2005 | 167 | 0.060 |
Why?
|
| Patient Discharge | 1 | 2003 | 93 | 0.060 |
Why?
|
| Patient Care Team | 1 | 2023 | 47 | 0.050 |
Why?
|
| Adaptation, Psychological | 1 | 2006 | 385 | 0.050 |
Why?
|
| Genes, BRCA2 | 1 | 2022 | 5 | 0.050 |
Why?
|
| Attitude | 1 | 2023 | 104 | 0.050 |
Why?
|
| Predictive Value of Tests | 3 | 2008 | 400 | 0.050 |
Why?
|
| Mouth Neoplasms | 1 | 2002 | 71 | 0.050 |
Why?
|
| Diabetes Complications | 1 | 2002 | 90 | 0.050 |
Why?
|
| Communication | 1 | 2023 | 180 | 0.050 |
Why?
|
| Precancerous Conditions | 1 | 2002 | 82 | 0.050 |
Why?
|
| Violence | 1 | 2002 | 134 | 0.050 |
Why?
|
| Africa | 1 | 2021 | 76 | 0.050 |
Why?
|
| Europe | 1 | 2021 | 101 | 0.050 |
Why?
|
| Homeodomain Proteins | 1 | 2022 | 132 | 0.050 |
Why?
|
| History, 19th Century | 1 | 2020 | 24 | 0.050 |
Why?
|
| Gene Expression Profiling | 1 | 2024 | 626 | 0.050 |
Why?
|
| Emotions | 1 | 2023 | 220 | 0.050 |
Why?
|
| Cause of Death | 1 | 2021 | 156 | 0.050 |
Why?
|
| Neoplasm Staging | 2 | 2014 | 275 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2003 | 935 | 0.040 |
Why?
|
| History, 20th Century | 1 | 2020 | 117 | 0.040 |
Why?
|
| Oligohydramnios | 2 | 2011 | 4 | 0.040 |
Why?
|
| Group Processes | 1 | 2019 | 21 | 0.040 |
Why?
|
| Trust | 1 | 2020 | 133 | 0.040 |
Why?
|
| Mental Disorders | 1 | 2002 | 309 | 0.040 |
Why?
|
| Cultural Characteristics | 1 | 2019 | 125 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2024 | 807 | 0.040 |
Why?
|
| Labor, Obstetric | 2 | 2008 | 16 | 0.040 |
Why?
|
| Feeding Behavior | 1 | 2002 | 454 | 0.040 |
Why?
|
| Educational Status | 2 | 2012 | 313 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 2017 | 11 | 0.040 |
Why?
|
| Genetic Variation | 1 | 2020 | 387 | 0.040 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2017 | 20 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2017 | 39 | 0.040 |
Why?
|
| Linkage Disequilibrium | 1 | 2017 | 85 | 0.040 |
Why?
|
| Parent-Child Relations | 1 | 2018 | 110 | 0.040 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2016 | 62 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2016 | 129 | 0.030 |
Why?
|
| Biopsy | 1 | 2016 | 164 | 0.030 |
Why?
|
| Quantitative Trait Loci | 1 | 2016 | 77 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2008 | 364 | 0.030 |
Why?
|
| Overweight | 2 | 2010 | 247 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2016 | 120 | 0.030 |
Why?
|
| Anxiety | 1 | 2022 | 754 | 0.030 |
Why?
|
| Diet Records | 1 | 2015 | 60 | 0.030 |
Why?
|
| Pesticides | 2 | 2006 | 52 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2016 | 1908 | 0.030 |
Why?
|
| Health Behavior | 2 | 2011 | 537 | 0.030 |
Why?
|
| Dietary Supplements | 1 | 2015 | 208 | 0.030 |
Why?
|
| Patient Care Planning | 1 | 2012 | 14 | 0.030 |
Why?
|
| Radiotherapy | 1 | 2012 | 18 | 0.030 |
Why?
|
| Polyhydramnios | 1 | 2011 | 2 | 0.030 |
Why?
|
| Professional-Patient Relations | 1 | 2012 | 48 | 0.030 |
Why?
|
| Preventive Health Services | 1 | 2012 | 64 | 0.030 |
Why?
|
| Prostatectomy | 1 | 2012 | 63 | 0.030 |
Why?
|
| Prognosis | 1 | 2014 | 739 | 0.020 |
Why?
|
| Sample Size | 1 | 2010 | 25 | 0.020 |
Why?
|
| Electric Impedance | 1 | 2010 | 25 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2010 | 77 | 0.020 |
Why?
|
| Public Assistance | 1 | 2010 | 27 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2012 | 381 | 0.020 |
Why?
|
| Uterus | 1 | 2010 | 55 | 0.020 |
Why?
|
| Glucose Transporter Type 2 | 1 | 2010 | 1 | 0.020 |
Why?
|
| TCF Transcription Factors | 1 | 2010 | 15 | 0.020 |
Why?
|
| Hospitals, Urban | 1 | 2010 | 39 | 0.020 |
Why?
|
| Hospitals, Teaching | 1 | 2010 | 27 | 0.020 |
Why?
|
| Calpain | 1 | 2010 | 35 | 0.020 |
Why?
|
| Ion Channels | 1 | 2010 | 71 | 0.020 |
Why?
|
| Peer Group | 1 | 2010 | 156 | 0.020 |
Why?
|
| Mitochondrial Proteins | 1 | 2010 | 107 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2010 | 339 | 0.020 |
Why?
|
| Apgar Score | 1 | 2008 | 5 | 0.020 |
Why?
|
| Trial of Labor | 1 | 2008 | 2 | 0.020 |
Why?
|
| Labor Stage, Second | 1 | 2008 | 2 | 0.020 |
Why?
|
| Emergency Treatment | 1 | 2008 | 13 | 0.020 |
Why?
|
| Observer Variation | 1 | 2008 | 52 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2008 | 117 | 0.020 |
Why?
|
| RNA-Binding Proteins | 1 | 2010 | 146 | 0.020 |
Why?
|
| Atherosclerosis | 1 | 2010 | 134 | 0.020 |
Why?
|
| Periodicals as Topic | 1 | 2008 | 49 | 0.020 |
Why?
|
| Patient Admission | 1 | 2008 | 41 | 0.020 |
Why?
|
| Humeral Fractures | 1 | 2007 | 1 | 0.020 |
Why?
|
| Clavicle | 1 | 2007 | 3 | 0.020 |
Why?
|
| Shoulder Fractures | 1 | 2007 | 2 | 0.020 |
Why?
|
| Gene Expression | 1 | 2010 | 674 | 0.020 |
Why?
|
| Heart Rate | 1 | 2008 | 253 | 0.020 |
Why?
|
| Fractures, Bone | 1 | 2007 | 53 | 0.020 |
Why?
|
| Fetal Membranes, Premature Rupture | 1 | 2006 | 7 | 0.020 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2006 | 16 | 0.020 |
Why?
|
| Digital Rectal Examination | 1 | 2006 | 4 | 0.020 |
Why?
|
| SEER Program | 1 | 2006 | 91 | 0.020 |
Why?
|
| Diabetes, Gestational | 1 | 2006 | 47 | 0.020 |
Why?
|
| Prostatic Hyperplasia | 1 | 2006 | 34 | 0.020 |
Why?
|
| Physical Fitness | 1 | 2006 | 90 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2007 | 448 | 0.020 |
Why?
|
| Umbilical Arteries | 1 | 2005 | 3 | 0.020 |
Why?
|
| Illegitimacy | 1 | 2005 | 1 | 0.020 |
Why?
|
| Probability | 1 | 2005 | 78 | 0.020 |
Why?
|
| Sex Education | 1 | 2005 | 30 | 0.020 |
Why?
|
| Fetal Blood | 1 | 2005 | 50 | 0.020 |
Why?
|
| Menopause, Premature | 1 | 2004 | 5 | 0.020 |
Why?
|
| Empathy | 1 | 2004 | 28 | 0.020 |
Why?
|
| Unemployment | 1 | 2004 | 23 | 0.020 |
Why?
|
| Electromagnetic Fields | 1 | 2004 | 8 | 0.020 |
Why?
|
| Infant, Low Birth Weight | 1 | 2004 | 39 | 0.020 |
Why?
|
| Benzene | 1 | 2004 | 16 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2004 | 215 | 0.010 |
Why?
|
| Linear Models | 1 | 2005 | 275 | 0.010 |
Why?
|
| Organic Chemicals | 1 | 2004 | 35 | 0.010 |
Why?
|
| Chemical Industry | 1 | 2003 | 2 | 0.010 |
Why?
|
| Solvents | 1 | 2004 | 99 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 2005 | 217 | 0.010 |
Why?
|
| Family | 1 | 2004 | 173 | 0.010 |
Why?
|
| Plant Extracts | 1 | 2006 | 286 | 0.010 |
Why?
|
| Iron, Dietary | 1 | 2002 | 13 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2002 | 111 | 0.010 |
Why?
|
| Substance-Related Disorders | 1 | 2010 | 730 | 0.010 |
Why?
|
| Dietary Fiber | 1 | 2002 | 47 | 0.010 |
Why?
|
| India | 1 | 2002 | 88 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2006 | 1369 | 0.010 |
Why?
|
| Sexual Partners | 1 | 2005 | 314 | 0.010 |
Why?
|
| Zinc | 1 | 2002 | 128 | 0.010 |
Why?
|
| Alcohol Drinking | 1 | 2005 | 519 | 0.010 |
Why?
|
| Rural Population | 1 | 2002 | 294 | 0.010 |
Why?
|